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Abstract 
 
Low levels of plasma high-density lipoprotein cholesterol (HDL-C) are associated with insulin 
resistance and type 2 diabetes (T2D). As it is well appreciated that hyperinsulinemia contributes 
to the progression/worsening of insulin resistance, we tested here if this key metabolic 
derangement impaired cellular mechanisms of HDL-C generation. An initial event in this process 
is the binding of apolipoprotein A1 (ApoA1) to the plasma membrane (PM)-localized ATP-
binding cassette cholesterol transporter protein ABCA1. Subcellular fractionation analyses 
revealed that 3T3-L1 adipocytes exposed to chronic insulin (12h, 5nM) displayed a 25% 
decrease (P<0.05) in PM ABCA1 content and a reciprocal increase in endosomal ABCA1 
content. These insulin-induced changes in cellular ABCA1 distribution occurred concomitantly 
with a decrease in ApoA1-mediated cellular cholesterol efflux. Consistent with 
endosomal/cytosolic cycling of the small molecular GTPase Rab8 playing a functional role in 
ABCA1 vesicle trafficking, we found a 50% increase (P<0.05) in endosomal Rab8 content and a 
30% decrease (P<0.05) in cytosolic Rab8 content. New data shows that increased HBP activity 
increases cholesterol biosynthesis and increased endosomal cholesterol content inhibits the 
functional cycling of Rab proteins. In line with these observations, we found that cells treated 
with the cholesterol-lowering agent methyl-β-cyclodextrin were protected against insulin-
induced defects in ABCA1/Rab8 vesicle trafficking and PM cholesterol accrual. These data are 
consistent with the concept that the coexistence of low plasma HDL-C with insulin resistance 
and T2D may reflect a negative influence of hyperinsulinemia on Rab8-mediated trafficking of 
ABCA1 to the PM for ApoA1-mediated cholesterol efflux. 
 
 
 
 
